Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Current Heart Failure Reports|October 22, 2014
Rationale and therapeutic opportunities for natriuretic peptide system augmentation in heart failurePaul M McKie, John C Burnett
Mayo Clinic Proceedings|August 12, 2005
B-type natriuretic peptide as a biomarker beyond heart failure: speculations and opportunitiesPaul M McKie, John C Burnett
Current Hypertension Reports|December 3, 2011
M-atrial natriuretic peptide: a novel antihypertensive protein therapyPaul M McKie, Tomoko Ichiki, John C Burnett
Current Heart Failure Reports|June 29, 2010
CD-NP: an innovative designer natriuretic peptide activator of particulate guanylyl cyclase receptors for cardiorenal diseasePaul M McKie, S Jeson Sangaralingham, John C Burnett
Journal of the American College of Cardiology|April 23, 2013
B-type natriuretic peptide and survival in hypertrophic cardiomyopathyJeffrey B Geske, Paul M McKie, Steve R Ommen, et al.
Cephalalgia : an International Journal of Headache|February 14, 2018
Neuroimaging utilization and findings in headache outpatients: Significance of red and yellow flagsNathan P Young, Muhamad Y Elrashidi, Paul M McKie, et al.
JACC. Basic to Translational Science|July 5, 2021
STOP-HF Trial: Higher Endogenous BNP and Cardiovascular Protection in Subjects at Risk for Heart FailureValentina Cannone, Mark Ledwidge, Chris Watson, et al.
Journal of Cardiac Failure|June 9, 2023
The Cardiorenal Effects of Chronic Phosphodiesterase-V Inhibition in Preclinical Diastolic Dysfunction (Stage B Heart Failure)Shravya Vinnakota, Fadi W Adel, Paul M McKie, et al.
Pageof 5